期刊文献+

Influence of folic acid and vitamin B12 combined therapy on plasma Hcy, inflammatory factor levels and blood vessels endothelial function in patients with vascular dementia and type H hypertension 被引量:1

在线阅读 下载PDF
导出
摘要 Objective:To investigate influence of folic acid and vitamin B12 combined therapy on plasma homocysteine (Hcy) level, blood vessels endothelial function and inflammatory factors in patients with vascular dementia and type H hypertension.Methods:100 cases of patients with vascular dementia and type H hypertension accorded with the inclusion criteria were selected as research objects. They were randomly divided as the control group and the therapeutic group, 50 cases each. For control group, Enalapril tablets were administered by mouth for treatment. For therapeutic group, folic acid and vitamin B12 treatment were provided on the basis of treatment for control group. Treatments were continued for 12 weeks. Plasma Hcy levels, inflammatory factors [(interleukin-6 (IL-6), interleukin-8 (IL-8) and hypersensitive C reaction protein (hs-CRP)], blood vessels endothelial function indexes variation in patients before and after treatment were observed and detected.Results:Plasma Hcy, IL-6, IL-8 and hs-CRP levels in two groups of patients after treatment were significantly decreased comparing with the same group before treatment, and the above index levels in therapeutic group after treatment were significantly lower than control group (P<0.05);For comparison of blood vessels endothelial function indexes in the patients, NO levels in two groups after treatment were increased in various degrees, and endothelin-1 (ET-1) were decreased. The differences between levels of the two indexes in therapeutic group before and after treatment were significant, and levels after treatment in therapeutic group were significantly better than in control group (P<0.05). While variations of the differences in control group before and after treatment were not significant (P>0.05);After treatment, diastolic pressure and systolic pressure in the two groups of patients were significantly improved comparing with before treatment (P<0.05). However, after treatment, the differences of levels between therapeutic group and control group were not significant (P>0.05). MMSE score in therapeutic group after treatment was significantly higher than before treatment, and significantly higher than in control group (P<0.05).Conclusions: Combined therapy of folic acid and vitamin B12 for treating vascular dementia with type H hypertension could effectively decrease plasma Hcy and inflammatory factor levels, and improve blood vessels endothelial function and dementia degree on patients. It has certain clinical value which deserves to be promoted.
出处 《Journal of Hainan Medical University》 2017年第5期152-156,共5页 海南医学院学报(英文版)
作者简介 Corresponding author:Hao-Te Chen,Department of Neurology,Huanggang Central Hospital Neurology,Huanggang 438000,China.
  • 相关文献

参考文献6

二级参考文献65

  • 1霍勇,徐希平.依靠我国循证医学证据,更加安全有效预防脑卒中——H型高血压防治的现状和展望[J].中国医学前沿杂志(电子版),2011,3(3):4-9. 被引量:30
  • 2张春英,于挺敏.叶酸,维生素B_(12)与缺血性脑血管病[J].中国社区医师(医学专业),2004,6(13). 被引量:1
  • 3Sacco RL, Adams R, Albers G, et al. Guidelines for prevention of stroke in patients with ischemic stroke or transient ischemic attack;a statement for healthcare professionals from the American heart association/American stroke association council on stroke: co sponsor by the council on cardiovascular radiology and intervention: the American academy of neurology affirms the value of this guideline[J ]. Circulation, 2006,113 (7) : e409-449.
  • 4Air obaidi, stubbs P, Amersey R, et al. Acute and convalescent change in plasma homocysteine level in acute coronary syndromes [J]. Heart ,2001,85(4) :380-384.
  • 5RyanTJ, AntmanEM, BrooksNH, etal. 1999 Update: ACC/ AHA Guidelines for the management of patients with acute myocardial infarction: Executive summary and recommendations: a report of the American college of cardiology/American heart association task force on practice guidelines (committee on management of acute myocardial infarction) [ J ]. Circulation, 1999, 190 (9) : 1016-1030.
  • 6Graham IM, Daly LE, Refsum HM, et al. Plasma homocysteine as a risk factor for vascular disease:The European Concerted Action Project[J]. JAMA, 1997,27(4) : 1775-1781.
  • 7Yeter E, Ozdemir L, Keles T, etal. Association of elevated plasma homocysteine levels with impaired ST-segment resolution after fibrinolytic therapy in acute ST-elevation myocardial infarction[J]. Coron Artery Dis,2008,19(3) :163-166.
  • 8Djuric D, Jakovljevic V, Rasic-Markovic A, et al. Homocysteine, folic acid and coronary arterydisease: possible impact on prognosis and therapy[J].lndian J Chest Dis Allied Sci,2008,50 (1):39-48.
  • 9Bokhari SW, Bokhari ZW, Zell JA, et al. Plasma homoeysteine levels and the left ventricular systolic function in coronary artery disease patients[J]. Coronary Artery Disease, 2005,16 ( 3 ) : 153- 162.
  • 10Ebbing M, Bleie, Ueland PM, et al. Mortality and cardiovascular events in patients treated with homocysteine-lowering B vitamins after coronary angiography: a randomized controlled trial[J]. JAMA,2008,20,300(7):795-804.

共引文献88

同被引文献20

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部